The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer? - Wikidata - awgldk - TriplyDB

The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer?

The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer?

http://www.wikidata.org/entity/Q33848437

about

Role of multiparametric magnetic resonance imaging in early detection of prostate cancer Magnetic resonance imaging for prostate cancer: Comparative studies including radical prostatectomy specimens and template transperineal biopsy Current role of multiparametric magnetic resonance imaging for prostate cancer Multiparametric-MRI in diagnosis of prostate cancer Integration of multiparametric MRI into active surveillance of prostate cancer.Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting.Multimodal imaging for improved diagnosis and treatment of cancers.Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension.Minimization of errors in biexponential T2 measurements of the prostate.Everyman's prostate phantom: kiwi-fruit substitute for human prostates at magnetic resonance imaging, diffusion-weighted imaging and magnetic resonance spectroscopy.Multiparametric MRI in the PSA screening era Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies.Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A Cancer Care Ontario clinical practice guideline Recent advances in surgical planning & navigation for tumor biopsy and resection The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update.Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy.Will Multi-Parametric Magnetic Resonance Imaging be the Future Tool to Detect Clinically Significant Prostate Cancer?Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.Optimizing Patient Population for MP-MRI and Fusion Biopsy for Prostate Cancer Detection.Implementation of Multi-parametric Prostate MRI in Clinical Practice.Score 3 prostate lesions: a gray zone for PI-RADS v2.Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.Long-term cancer control outcomes of robot-assisted radical prostatectomy for prostate cancer treatment: a meta-analysis.Magnetic Resonance Image-Guided Focal Prostate Ablation.Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology.Advances in Imaging in Prostate and Bladder Cancer.Magnetic resonance imaging detection of prostate cancer in men with previous negative prostate biopsy.Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy.Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric study.Prostate diffusion imaging with distortion correction Magnetic resonance imaging detected prostate evasive anterior tumours: Further insights 1.5-Tesla Multiparametric-Magnetic Resonance Imaging for the detection of clinically significant prostate cancer.A systematic review on multiparametric MR imaging in prostate cancer detection.Accuracy of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate cancer: systematic review and meta-analysis.What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate.18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.Role of multi-parametric MRI of the prostate for screening and staging: Experience with over 1500 cases.

P2860

Q26768765-1B678373-6282-4E43-8AD1-EAEC32158482 Q26771360-5D5C538F-3188-4425-9615-558B32E28B54 Q26774839-3180B2AC-6477-4F27-989B-551815F668D3 Q28081873-61E050CA-8AD0-4216-BDD2-C08F8F5C742B Q30249514-D5FC3011-C717-43B5-93B7-97C4692E7E39 Q30837344-3BB06109-4BEE-4BB7-AE7B-CF5BCFDDADA7 Q30849413-5B232748-7585-48F4-8297-EA2F0AF30F48 Q30882787-94F99B4A-2F9B-42F6-8FBB-26441C156FE0 Q30897579-17414532-189E-4D9F-A495-22587BB421AA Q31153190-955123F3-3E10-456F-B1E3-148B87FB2388 Q34177428-120205B6-5EAD-4B04-9078-775F1C12227F Q35852107-35227400-56DA-437B-99BB-ABACE6C1344A Q36271105-225A13F6-376A-4F3F-9271-CE3FF8A442D1 Q36352653-EED982CD-A900-4234-8624-2134EA04B39F Q36411193-0FC16C7E-E65C-4428-A7EF-1C2588DEB6A5 Q36649765-89D0641E-9F97-470E-9F0E-9BC899EEDCAB Q36946259-1853EE4A-6FB0-4CDA-A7CA-4A74B860533F Q38269520-B5B6348A-2C4A-4CA5-9436-DF58845DA758 Q38341413-F75020D2-58F2-4529-BD47-B79529F96F75 Q38524498-C9C214F1-D512-4628-9C73-445E866C0900 Q38528397-E035413B-0DA2-4463-BB98-31DE87F73CFC Q38598713-747579C0-E693-4FF6-8D46-84E884A23D91 Q38842683-AF6D7281-8F09-495A-A975-68FFBC0651DF Q38941692-864E4C4C-6705-4815-B98F-732924114102 Q38943191-823996D7-1BA7-4680-A3E7-5BF794B8B92F Q39177286-0268A4A6-67A3-4642-92D6-7CE3B9951417 Q39441078-8E982AFE-6958-4C37-9E85-0ED380604430 Q39446406-208C0141-B4A8-4F63-820D-30399948926F Q39863303-E16E916C-4B0C-4A45-BE12-963516297AE8 Q40199490-E08CFFB0-56C9-4675-A244-999DDB0F2D8F Q40224363-89E17581-206E-4C94-B298-27B054D94BA4 Q40316580-4B874382-0CE0-4401-94D9-A8C3D00399F4 Q40684010-3E55A32E-B9D9-4264-9134-C9F5F273FE59 Q40899372-C9BAD55C-B95F-449E-8813-0086027385AC Q42321987-659A7AE8-FA83-4A00-B958-9240011CE5C0 Q43274222-52CFB8F6-90CC-4774-BB74-99DB14414DE7 Q47113442-E286AC3D-3BA4-4284-84B2-88E5E457D7B8 Q47753876-CE80C750-9398-49F9-BD13-FB4C7828BA4B Q50315275-9ED0F5BB-1DF4-4627-A2E5-F7F9C070A217 Q52741581-2314365B-FC4B-49D1-B571-176C8A7A83C4

P2860

The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer?

http://www.wikidata.org/entity/Q33848437

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

The accuracy of multiparametri ...... y significant prostate cancer?

@ast

The accuracy of multiparametri ...... y significant prostate cancer?

@en

type

label

The accuracy of multiparametri ...... y significant prostate cancer?

@ast

The accuracy of multiparametri ...... y significant prostate cancer?

@en

prefLabel

The accuracy of multiparametri ...... y significant prostate cancer?

@ast

The accuracy of multiparametri ...... y significant prostate cancer?

@en

P1433

Q33848437-C574E8C3-CACC-4C4A-9BE2-29B1E402C026

P1476

Q33848437-6E9438A9-2278-4D8C-A24D-D7560FCFB378

P2093

Q33848437-034EC871-73CA-4528-8AD1-22F383558559

Q33848437-243A4FF0-5865-49D7-979D-0F7B3D82306C

Q33848437-3E290499-FD72-432B-A853-657065BC8B86

Q33848437-AC09DAEC-4D4B-4B91-9AF7-1A60B776C239

Q33848437-BADBB4B0-60D8-4B2E-B6CD-18E913BE77D4

Q33848437-E6664248-316A-4E54-884B-BFF3A37E4ADD

Q33848437-F7A7C055-1940-46DC-B834-6502D3D1ADA4

P2860

Q33848437-16922A15-9DC9-4F4F-A12B-D5C39FFA6287

Q33848437-280C2C3F-CBDA-467C-BE10-D68BB66C06DC

Q33848437-29740434-D5D3-49E6-B268-8FE685ED7CDA

Q33848437-49177C2D-2DA9-4F34-84F3-28FE2C1CA5DE

Q33848437-58B0A1AE-AF88-4D1F-9578-82AE08F277D9

Q33848437-6634427F-B5B7-4A08-82D7-03890B5ECD2E

Q33848437-779376A2-3393-4831-ACE2-8A03FBD059B4

Q33848437-8EA5340F-856D-4B92-9903-A82EC8A076F8

Q33848437-AD19049F-6602-402B-B89F-74DBCE9FD0ED

P304

Q33848437-2107F470-80ED-4F62-A88B-64C225991FD9

P31

Q33848437-FBAFFF06-2B30-4D29-9C1E-D2F57AC71075

P356

Q33848437-D25C0903-AAFB-4C35-8681-B621D751835B

P433

Q33848437-E5E6371B-0758-4DD6-8D95-FDA87F54BE4E

P478

Q33848437-1FE53552-7A2C-48D4-ABB5-E29C366F60E6

P50

Q33848437-D84E6D18-4B50-4850-92A5-248F0F97E2CC

P577

Q33848437-F8542917-97AC-4DEB-B474-34050B323A1A

P5875

Q33848437-983588E0-A3CB-42EE-9BBA-8EFCEC53E796

P698

Q33848437-1BC937C6-82F0-4FF7-B860-56FD82761827

P932

Q33848437-1666B097-CDD4-43F6-95C1-71A3A7C5A221

P356

J.UROLONC.2013.06.007

P1433

Urologic Oncology

P1476

The accuracy of multiparametri ...... y significant prostate cancer?

@en

P2093

Alex Freeman

http://www.w3.org/2001/XMLSchema#string

Alex Kirkham

http://www.w3.org/2001/XMLSchema#string

Eleni Anastasiadis

http://www.w3.org/2001/XMLSchema#string

Hashim U Ahmed

http://www.w3.org/2001/XMLSchema#string

Manit Arya

http://www.w3.org/2001/XMLSchema#string

Mohamed Abd-Alazeez

http://www.w3.org/2001/XMLSchema#string

Susan C Charman

http://www.w3.org/2001/XMLSchema#string

P2860

ESUR prostate MR guidelines 2012

Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients.

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

How good is MRI at detecting and characterising cancer within the prostate?

Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning.

Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard.

High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread.

Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy.

P304

45.e17-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.UROLONC.2013.06.007

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256929130

http://www.w3.org/2001/XMLSchema#string

P698

24055430

http://www.w3.org/2001/XMLSchema#string

P932

4082533

http://www.w3.org/2001/XMLSchema#string